Company
Crossfire Oncology
Approaching kinases. From every angle.
Also known as Crossfire Oncology B.V.
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Headquarters
- Oss, The Netherlands
- Legal name
- Crossfire Oncology B.V.
- crossfire-oncology.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
At Crossfire we approach kinases from three different angles: inhibitors, degraders, and degrader antibody conjugates. This tailored approach allows us to design kinase targeting drugs that aim to maximize the therapeutic benefit for cancer patients.
Loading relationship preview